glp 1 parkinson's triple acting disease agonist glp-1 gip glucagon clinical trial Current Insights, Advantages and Challenges of Triple GLP-1 / GIP GLP-1 Signalling as a Therapeutic

The goal isnt perfection its creating meals that keep you fuller for longer while reducing the cycle of cravings and overeating.

High-fibre foods (oats, millets, vegetables, legumes) feed gut bacteria that stimulate natural GLP-1

2 Current perspective on DPN 2.1 Prevalence of DPN The prevalence of DPN varies among different countries and regions

DapasMLinFNadkarniGSiskRLegroRUrbanekMet al

Rakow A, Kowski A, Treskatsch S, et al

We further explore the potential actions of multi-agonist drugs as well as the mechanisms through which gut-brain communication can be used to achieve long-term weight loss without negative side effects